Charles L. Loprinzi

Dec 20, 2024 | mdpi.com | Charles L. Loprinzi

1. IntroductionOxaliplatin, paclitaxel, and cisplatin are important chemotherapy agents. Paclitaxel is essential in the management of lung cancer, breast cancer, and gynecological malignancies; oxaliplatin has been critical in treating gastrointestinal cancers; and cisplatin has been used in a variety of cancers [1,2,3,4,5,6,7]. Unfortunately, a significant side effect that can limit treatment with these drugs is chemotherapy-induced peripheral neuropathy (CIPN) [8,9].

Feb 22, 2024 | nature.com | Samantha Mannion |Alexandra Higgins |Nicole I Larson |Elizabeth Stewart |Zaraq Khan |Chandra C. Shenoy | +6 more

AbstractSurvey data from the Mayo Clinic Breast Disease Registry were used to assess fertility counseling and fertility preservation strategies in a modern cohort of young women with breast cancer. One hundred respondents were identified who were under age 50 at the time of breast cancer diagnosis and who expressed interest in future childbearing near the time of diagnosis and/or 1 year later.

Jul 12, 2023 | nejm.org | Thomas Smith |Eric Wang |Charles L. Loprinzi |Dan L. Longo

This article is available to subscribers. Subscribe now. Already have an account? Sign in Review ArticleList of authors. Thomas J. Smith, M.D., Eric J. Wang, M.D., and Charles L. Loprinzi, M.D. Article Figures/Media Metrics Related ArticlesThe authors discuss two forms of cutaneous electroanalgesia for pain relief — transcutaneous electrical nerve stimulation and scrambler therapy — addressing technology, safety, and results from randomized trials.

Jul 12, 2023 | nejm.org | Thomas Smith |Eric Wang |Charles L. Loprinzi |Dan L. Longo

This article is available to subscribers. Subscribe now. Already have an account? Sign inThe authors discuss two forms of cutaneous electroanalgesia for pain relief — transcutaneous electrical nerve stimulation and scrambler therapy — addressing technology, safety, and results from randomized trials. Create your account to get 2 free subscriber-only articles each month. Get Free Access Now Subscribe For Full Access Already have an account? Sign In Activate your online access.